The Centers for Disease Control and Prevention has recommended that the U.S. resume the use of the Johnson & Johnson COVID-19 vaccine. According to CNBC, the CDC advisory panel said the benefits outweigh the risk. The pause was announced on April 13 after the vaccine was linked to a rare blood clotting disorder known as cerebral venous sinus thrombosis. RELATED: FDA asks states to temporarily halt use of Johnson & Johnson COVID-19 vaccine A total of 13 reported cases were found in women between the ages of 18-49 and two in women 50 and older, NPR reported. Three of the 15 […]
The post CDC: US should resume use of Johnson & Johnson COVID-19 vaccine appeared first on BNC.
